In Reply To: Comment on: Improved Local Control following Dose-Escalated Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Sarcomas: An International Multi-Institutional Experience

Radiother Oncol. 2023 Dec 18:110058. doi: 10.1016/j.radonc.2023.110058. Online ahead of print.NO ABSTRACTPMID:38122853 | DOI:10.1016/j.radonc.2023.110058
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Source Type: research